
Talkspace (TALK) Stock Forecast & Price Target
Talkspace (TALK) Analyst Ratings
Bulls say
Talkspace is expected to go through a significant increase in outpatient growth as UHS acquires them for their extensive network of licensed professionals and expands their access to commercially insured populations. The deal, priced at a $5.25 per share and a total enterprise value of approximately $835 million, is an ~11% premium to Talkspace's previous closing price and represents a strategic move for UHS to diversify their revenue streams beyond core acute volumes. The acquisition is expected to be slightly accretive to UHS's adjusted net income within the first 12 months and increasingly accretive thereafter.
Bears say
Talkspace is weathering multiple risks including clients not renewing subscriptions and the highly competitive healthcare industry. Additionally, healthcare regulations on virtual prescriptions and possible breaches of confidentiality could negatively impact their operations. Furthermore, their recent acquisition deal at a premium price signals that the market may have already priced in much of their potential success, prompting an overall hold rating for the stock.
This aggregate rating is based on analysts' research of Talkspace and is not a guaranteed prediction by Public.com or investment advice.
Talkspace (TALK) Analyst Forecast & Price Prediction
Start investing in Talkspace (TALK)
Order type
Buy in
Order amount
Est. shares
0 shares